Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:
Sign Up
| Overall Assessment |
Comment |
Score |
| None |
No evidence found
|
0
|
| Overall Assessment |
Comment |
Score |
| None |
Catalent Inc. does not disclose any specific governance processes to ensure its lobbying or policy-influencing activities align with its climate commitments. While the company states that its “external engagement activities are consistent with [its] climate commitments and/or climate transition plan” and notes that it is “part of the pharma industry associations in multiple countries where we operate,” it provides no detail on the mechanisms, oversight structures, or accountability measures used to govern such engagement. The evidence also mentions that these associations made a “joint industry statement at the COP26 related to actions to tackle climate change” and that Catalent is “committed to the PSCI principles,” yet there is no information on how Catalent monitors, reviews, or enforces alignment of indirect lobbying through these associations, nor does it disclose any individual or formal body responsible for overseeing lobbying alignment. We found no evidence of a policy to ensure lobbying alignment, nor any processes for board sign-off, periodic reviews, or third-party audits of its lobbying activities.
|
0
|